<DOC>
	<DOCNO>NCT00395681</DOCNO>
	<brief_summary>Rationale : The extreme increase obesity last year lead study . There consensus anaesthetise morbidly obese patient . The amount narcotic give vary widely rather depend anaesthetist pharmacokinetics dynamic morbidly obese patient . Reason clear extend pharmacokinetics dynamic affect morbidly obese patient . Objective : The study perform order develop population pharmacokinetic pharmacodynamic model Propofol use induction maintenance anaesthesia morbidly obese patient ( BMI &gt; 40 ) . A covariate analysis perform order account variability pharmacokinetic and/or pharmacodynamic parameter . This model take account patient procedure bound covariates . The result use develop individualised dose scheme Propofol use induction maintenance anaesthesia morbidly obese patient . Study design : A randomised , therapeutic non-invasive study . Study population : Morbidly obese patient Body Mass Index &gt; 40 undergoing laparoscopic band gastric bypass surgery , 18-60 year old . Intervention ( applicable ) : Patients randomise two group , one group give 200 milligram Propofol group give 350 milligram Propofol . During induction anaesthesia Propofol 60 second , patient ask count order measure time induction anaesthesia . During follow anaesthesia maximum 50 ml blood take indwell arterial line . Depth sedation measure use non-invasive Bispectral Index ( target 40-60 ) standard measure ( heart frequency blood pressure ) . Main study parameters/endpoints : Primary endpoint : pharmacokinetic parameter ; clearance , intercompartmental clearance , volume central compartment volume peripheral compartment . Secondary endpoint : pharmacodynamic parameter ; time induction anaesthesia ( stop counting , eyelash reflex , quality anaesthesia , correspond dose require induction anaesthesia induction dos ) , EC50 use BIS , require dos Propofol maintenance anaesthesia , wake-up time . Nature extent burden risk associate participation benefit group relatedness : A maximum amount 50 milliliter blood sample indwell arterial line . The patient ask count slowly induction anaesthesia . Both induction dose 200 350 milligram currently use standard induction dos morbidly obese patient .</brief_summary>
	<brief_title>Population PK/PD Propofol Morbidly Obese Patient</brief_title>
	<detailed_description>1 . INTRODUCTION AND RATIONALE The extreme increase obesity last year lead study . There consensus anaesthetise morbidly obese patient . The amount narcotic give induction maintenance anaesthesia vary widely rather depend anaesthetist pharmacokinetics dynamic morbidly obese patient ( see figure 1 2 ) . Despite large range induction dos ( 200-800 milligram Propofol , figure 1 ) , quality induction anaesthesia prove adequate case . This explained central volume distribution , probably morbidly obese patient normal weight patient . This mean induction dose Propofol adjust morbidly obese patient induction dose non-obese patient apply , 200 milligram ( +/- 2.5 mg/kg ) . For maintenance anaesthesia , however , pharmacokinetic parameter clearance peripheral volume distribution play important role probably alter morbidly obese patient . Because clear pharmacokinetics dynamic affect morbidly obese patient , study perform order develop population pharmacokinetic pharmacodynamic model Propofol use induction maintenance anaesthesia morbidly obese patient ( BMI &gt; 40 ) . In clinic several study perform pharmacokinetic pharmacodynamic relation Propofol non-obese patient . There two study induction anaesthesia12 . One study describe sedation follow cardiac surgery3 . There also four study describe sedation critically ill patient45 children67 . 2 . OBJECTIVES The study perform order develop population pharmacokinetic pharmacodynamic model Propofol morbidly obese patient . A covariate analysis perform order account variability pharmacokinetic pharmacodynamic parameter . The result use develop individualised dose scheme Propofol morbidly obese patient . This model take account patient procedure bound covariates . Primary Objective : The main objective develop pharmacokinetic model Propofol use induction maintenance anaesthesia morbidly obese patient . Pharmacokinetic parameter clearance , intercompartmental clearance , volume central compartment volume peripheral compartment . Secondary Objective ( ) : The secondary objective develop pharmacodynamic model Propofol morbidly obese patient , use Bispectral Index haemodynamics ( heart rate blood pressure ) pharmacodynamic endpoint . Pharmacodynamic parameter ; time induction anaesthesia ( stop counting , eyelash reflex , quality anaesthesia , correspond dose require induction anaesthesia induction dos ) , EC50 use BIS , require dos Propofol maintenance anaesthesia , wake-up time . A covariate analysis perform order account variability pharmacokinetic pharmacodynamic parameter . Covariates : body weight , body mass index , lean body mass , length , age , PEEP open laparoscopic procedure , renal hepatic function test , haemodynamic parameter , use co-medication . 3 . STUDY DESIGN This randomise , therapeutic noninvasive study , mean whole procedure standard except additional blood sample indwell arterial line follow anaesthesia . The induction dose ( 200 mg 350 mg ) consider standard dos , survey induction dose find vary 200 800 milligram ( unpublished data ) . Morbidly obese patient , 18-60 year old , Body Mass Index &gt; 40 undergoing laparoscopic band gastric bypass surgery include . Before induction investigator install antecubital infusion line , indwell arterial blood pressure line , Bisprectal Index ( BIS ) 3-lead ECG . The investigator give 2 millilitre Lidocaine prior infusion Propofol 2 % avoid pain injection . Anaesthesia induce bolus 200 milligram 350 milligram Propofol 2 % 60 second deliver Graseby Medical 3400 pump . Patients give premedication . During bolus injection patient ask count . At moment patient stop count blind observer note time BIS evaluate presence eyelash reflex . When total amount Propofol 2 % give blind observer note BIS presence eyelash reflex 250 microgram Fentanyl 50 milligram Atracurium give . The BIS note patient intubate mechanically ventilate . The ventilation mode note , well amount PEEP pneumoperitoneum use investigator note intra-abdominal pressure . The BIS monitor depth anaesthesia continuously data record interval 30 second . Anaesthesia maintain aim Bispectral Index 40 60 . The investigator start Propofol 2 % infusion rate 25 % total body weight ( 5 mg/kg/hr ) , ability change aim BIS reach . Remifentanyl ( 2 mg Remifentanyl 40 ml NaCl 0.9 % ) Atracurium ( 150 mg Atracurium 50 ml NaCl 0.9 % ) standardise infusion rate 25 % ideal body weight 10 % total body weight respectively . Blood sample take indwell arterial line , exact time record sample . At point sample investigator note BIS . If infusion Propofol 2 % change , time BIS note . Extra blood sample take moment change infusion rate 5 15 minute change infusion rate . All sample collect glass oxalate tube analyse within three month . At end operation Propofol 2 % , Remifentanyl Atracurium stop 10 milligram Morphine give intravenously . Atracurium antagonise Neostigmine 1.5 milligram Atropine 0.5 milligram . Postoperative pain relief standardise intravenous Diclofenac 3 time 75 milligram , intravenous Paracetamol 4 time 1000 milligram subcutaneous Morfine 4 time 10 milligram . 4.1 Population ( base ) Morbidly obese patient Body Mass Index &gt; 40 undergoing laparoscopic band gastric bypass surgery , 18-60 year old 4.2 Inclusion criterion Patients Body Mass Index &gt; 40 undergoing laparoscopic band gastric bypass surgery . 4.3 Exclusion criterion Epilepsy , pregnancy , breastfeed know allergy Propofol , egg lecithin soy bean oil . 4.4 Sample size calculation In study , 20 morbidly obese patient include . For determination pharmacokinetic parameter , normally 8-10 patient require optimal circumstance . Because clinical situation operation room less optimal compare phase I study human volunteer result additional variability , generally accept include 20 patient result reliable model previous study group</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<criteria>Patients Body Mass Index &gt; 40 undergoing laparoscopic band gastric bypass surgery . Epilepsy , pregnancy , breastfeed know allergy Propofol , egg lecithin soy bean oil .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Propofol</keyword>
	<keyword>Morbidly obese</keyword>
	<keyword>BMI</keyword>
</DOC>